nanoprimer

CURADIGM ANNOUNCES THE SELECTION OF ITS NANOPRIMER TECHNOLOGY BY THE NATIONAL CANCER INSTITUTE

CURADIGM ANNOUNCES THE SELECTION OF ITS NANOPRIMER TECHNOLOGY BY THE NATIONAL CANCER INSTITUTE

The broad utility of the Nanoprimer technology is due to its unique nanomedicine approach to improve therapeutic action without modifying the therapeutic in any way. Rather, the Nanoprimer is administered intravenously just prior to a therapeutic, specifically and transiently occupying the liver pathways responsible for clearance. This temporarily increases the therapeutic’s bioavailability and subsequent accumulation in target tissue. […]

Continue Reading...